A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

Clinical trial NCT06870487 · TERMINATED

Trial details

NCT number: NCT06870487
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma Diffuse Large B-cell Lymphoma Classical Hodgkin Lymphoma Head and Neck Squamous Cell Carcinoma Melanoma Non-Small Cell Lung Cancer

Start date: 2025-05-08
Primary completion: 2026-04-23
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.